Human medicines European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly), tadalafil, Date of authorisation: 01/10/2008, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 7, Status: Authorised
Member states contact points for review of national versions of the content of mobile scanning and other technologies
Nitrosamine in vivo mutagenicity workshop, European Medicines Agency, Amsterdam, the Netherlands, from 11 July 2024, 12:00 (CEST) to 12 July 2024, 15:00 (CEST)
Minutes of the PRAC meeting 13-16 May 2024
List of medicines currently in PRIME scheme
Procedural advice on paediatric applications
Menopur (menotropin) supply shortage
How do we ensure faster and better clinical trials in the EU? – Peter Arlett and Marianne Lunzer respond to questions about ACT-EU on LinkedIn live, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 July 2024, 12:00 (CEST) to 16 July 2024, 12:30 (CEST)
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool (EVWEB) user manual